Veterinary Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。 詳細はお問い合わせください。
ページ情報: 英文 147 Pages
The global veterinary diagnostics market size reached US$ 6.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 9.8 Billion by 2028, exhibiting a growth rate (CAGR) of 8.2% during 2022-2028. The growing number of pet ownerships, increasing demand for preventive care of pets, and rising awareness about zoonotic diseases, which can be transmitted between animals and humans, are some of the major factors propelling the market.
Veterinary diagnostics are used by veterinarians to identify and diagnose diseases, injuries, and other health conditions in animals. They are crucial for providing appropriate medical care and developing effective treatment plans for animals. They enable veterinarians to accurately identify the specific health condition or disease affecting an animal. They allow for early detection of diseases, often before clinical signs are evident. They also provide valuable information that helps veterinarians adjust treatment plans and manage long-term conditions effectively. They aid in identifying zoonotic diseases in animals, enabling appropriate measures to control the spread of these diseases and protect both animal and human populations.
At present, the increasing demand for veterinary diagnostics due to the rising number of pet clinics around the world is impelling the growth of the market. Besides this, the increasing prevalence of infectious diseases, chronic conditions, and age-related ailments in animals is contributing to the growth of the market. In addition, the growing technological advancements in veterinary diagnostics for improving the accuracy, efficiency, and speed of diagnostic tests are offering a favorable market outlook. Apart from this, the increasing emphasis on preventive healthcare in veterinary medicine is supporting the growth of the market. Additionally, the rising awareness about zoonotic diseases, which can be transmitted between humans and animals, is strengthening the growth of the market. Moreover, the increasing number of individuals who are willing to invest in advanced medical care for their pets is bolstering the growth of the market.
Rising number of pet ownerships
At present, there is a rise in the number of pet ownership worldwide, driven by changing lifestyles, urbanization, and the growing awareness about the health benefits associated with pet companionship. Pets offer unconditional love, loyalty, and can be a source of comfort and stress relief. Apart from this, the availability of pet-related resources, such as pet stores, veterinary services, pet-friendly establishments, and online platforms, for purchasing pet supplies, is making pet ownership more accessible and convenient. Moreover, the increasing awareness and concern about animal welfare is playing a significant role in the rise of pet ownership. People are increasingly adopting pets from animal shelters and rescue organizations, giving abandoned or neglected animals a better care. Furthermore, as more people consider their pets as family members, the demand for veterinary diagnostics is increasing around the world.
Increasing emergence of advanced diagnostic technologies
Advanced diagnostic technologies are revolutionizing veterinary diagnostics, enabling more accurate and efficient identification of diseases and health conditions in animals. It involves the analysis of genetic material to detect and identify specific pathogens, genetic abnormalities, and disease markers. Apart from this, various techniques, such as polymerase chain reaction (PCR), real-time PCR, deoxyribonucleic acid (DNA) sequencing, and microarrays, allow for the detection of infectious agents, genetic diseases, and cancer mutations with high sensitivity and specificity. Advanced veterinary diagnostic techniques are also useful for detecting complex fractures, and tumors. It provides superior visualization of the brain, spinal cord, joints, and soft tissue structures.
Increasing awareness about preventive care of pets
At present, there is an increase in awareness about preventive care of pets as it enhances the overall health conditions of animals and improves their survival rates. Apart from this, online resources, websites, forums, and social media platforms provide pet owners with information on preventive measures, routine vaccinations, wellness screenings, and the importance of regular veterinary check-ups. This, in turn, is empowering pet owners to take proactive measures in caring for their pets. Moreover, advancements in veterinary diagnostics are contributing to the awareness and importance of preventive care. Veterinary professionals are acquiring a better understanding of disease prevention, vaccination schedules, and the benefits of regular screenings. They can educate pet owners about preventive care measures and provide evidence-based recommendations for keeping pets healthy.
IMARC Group provides an analysis of the key trends in each segment of the global veterinary diagnostics market report, along with forecasts at the global, regional and country levels from 2023-2028. Our report has categorized the market based on product, technology, animal type, disease type and end user.
Kits and Reagents
Software and Services
Kits and reagents dominate the market
The report has provided a detailed breakup and analysis of the market based on the product. This includes instruments, kits and reagents, and software and services. According to the report, kits and reagents represented the largest segment.
Kits and reagents play a crucial role in veterinary diagnostics and provide essential tools and substances for conducting various diagnostic tests. They include pre-packaged reagents and instructions for conducting tests, such as enzyme-linked immunosorbent assays (ELISAs) or polymerase chain reaction (PCR) assays. The reagents in these kits are designed to detect specific pathogens or disease markers, allowing veterinarians to diagnose infectious diseases spontaneously and accurately in animals. They are also used to measure parameters, such as complete blood counts, blood chemistries (including liver and kidney function), electrolyte levels, and blood clotting abilities. They assist in detecting abnormalities, such as the presence of bacteria, parasites, blood, or abnormal levels of certain chemicals or metabolites.
Clinical biochemistry holds the largest share in the market
A detailed breakup and analysis of the market based on the technology has also been provided in the report. This includes immunodiagnostics, clinical biochemistry, molecular diagnostics, hematology, and others. According to the report, clinical biochemistry accounted for the largest market share.
Clinical biochemistry is a fundamental component of veterinary diagnostics that involves the analysis of blood and other body fluids to assess the physiological and biochemical status of animals. It provides valuable information about organ function, metabolic processes, and the presence of diseases or abnormalities. It helps measure a wide range of parameters, including enzymes, electrolytes, proteins, metabolites, hormones, and waste products. It encompasses various tests, which are conducted using specialized laboratory equipment and reagents. It also focuses on providing quantitative data that helps veterinarians in the diagnosis, monitoring, and treatment of various conditions. Furthermore, by evaluating the levels of specific analytes in the blood, such as liver enzymes, kidney function markers (creatinine), glucose, albumin, and electrolytes (sodium and potassium), clinical biochemistry aids in the detection of organ dysfunction, nutritional imbalances, endocrine disorders, and metabolic abnormalities in animals.
Livestock animals hold the maximum share of the market
A detailed breakup and analysis of the market based on the animal type have also been provided in the report. This includes companion animals (dogs, cats, and others) and livestock animals (cattle, swine, poultry, and others). According to the report, livestock animals (cattle, swine, poultry, and others) accounted for the largest market share.
Livestock animals, such as cattle, pigs, sheep, and poultry, require veterinary diagnostics as it helps identify and diagnose diseases effectively. Early detection is crucial for implementing appropriate control measures to restrict the spread of infectious diseases within herds or flocks. Besides this, diagnostic tests enable veterinarians to accurately identify the causative agents, determine the extent of disease prevalence, and guide the implementation of effective treatment and preventive strategies. Veterinary diagnostic testing also helps assess the health and productivity of individual animals and the overall herd or flock. By monitoring various parameters, such as blood chemistry, fecal quality, and growth rates, veterinarians can identify and address health issues that may affect production efficiency, including nutritional deficiencies, parasitic infections, metabolic disorders, and respiratory diseases.
Hereditary, Congenital and Acquired Diseases
Structural and Functional Diseases
Non-infectious diseases account for the majority of market share
A detailed breakup and analysis of the market based on the disease type have also been provided in the report. This includes infectious diseases, non-infectious diseases, hereditary, congenital, and acquired diseases, general ailments, and structural and functional diseases. According to the report, non-infectious diseases accounted for the largest market share.
Veterinary diagnostics play a crucial role in identifying infectious diseases in animals, as accurate and timely diagnosis is essential for appropriate treatment and control measures. It is essential for disease surveillance and monitoring in animal populations. By conducting diagnostic tests on individual animals or within herds or flocks, veterinarians can assess the prevalence, spread, and impact of infectious diseases. It also aids in identifying various zoonotic diseases in animals, helping prevent or minimize the transmission of pathogens from animals to humans. By diagnosing and managing infectious diseases in animals, veterinary diagnostics contribute to protect public health and prevent the spread of zoonotic infections.
Veterinary Hospitals and Clinics
Reference laboratories hold the largest share in the market
A detailed breakup and analysis of the market based on the end-user have also been provided in the report. This includes reference laboratories, veterinary hospitals and clinics, and others. According to the report, reference laboratories accounted for the largest market share.
Reference laboratories play a vital role in veterinary diagnostics by providing specialized and advanced diagnostic services to support veterinarians, clinics, and research institutions. They are equipped with state-of-the-art technology, highly trained personnel, and expertise in a wide range of veterinary diagnostic disciplines. They offer a comprehensive number of diagnostic tests that may not be available at local veterinary clinics or laboratories. They often possess a broader test menu and the capacity to perform essential tests that require specialized equipment, techniques, or expertise. Reference laboratories can perform highly specific and sensitive tests to detect infectious agents, identify genetic disorders, diagnose complex diseases, and assess the overall health status of animals.
Middle East and Africa
North America exhibits a clear dominance, accounting for the largest veterinary diagnostics market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.
North America held the biggest market share due to the increase in veterinary specialty practices and referral centers. Besides this, the rising focus on pet health and wellness and advanced veterinary medicine is propelling the growth of the market.
Another contributing aspect is the increasing demand for preventive healthcare, early disease detection, and personalized treatment options to ensure their pets lead long and healthy lives is propelling the growth of the market.
Asia Pacific is estimated to expand further in this domain due to rising adoption of pets among millennials. Besides this, the increasing expansion of livestock and aquaculture industries is bolstering the growth of the market.
Key market players in the market are implementing various strategies and initiatives to improve their business. They are investing in research and development (R&D) activities to innovate and develop new diagnostic technologies, tests, and products. They are also focusing on improving the accuracy, efficiency, and speed of veterinary diagnostic tests, as well as expanding the range of diseases and conditions that can be diagnosed. Top companies are actively pursuing strategic partnerships and acquisitions to expand their product offerings, geographical reach, and market share. They are also providing telemedicine services to pet owners, comprising of consultation, monitoring, and remote diagnostic in certain scenarios. Leading companies are embracing artificial intelligence (AI), machine learning (ML), and molecular diagnostics to improve their product offerings and service delivery.
IDEXX Laboratories Inc.
Randox Laboratories Ltd.
Thermo Fisher Scientific Inc.
In April 2020, BioChek B.V. announced the successful acquisition of BIOTECON to create a new global player in veterinary and food safety solutions.
In June 2023, IDEXX Laboratories Inc. announced the launch the first veterinary diagnostic test of for detecting kidney injury in cats and dogs.
In April 2023, Mars, Incorporated and Heska Corporation announced that they had entered into an agreement under which Mars agreed to acquire Heska for $120.00 per share, enabling broader coverage across diagnostics and technology, while accelerating R&D and expanding access globally to pet healthcare solutions.